 My name is Edward Statenauer. I'm a professor of medicine and chief of hematologic malignancies at the Aberson Cancer Center of the University of Pennsylvania in Philadelphia, PA. Therapy for myeloma has really changed over the last decade. In fact, it is one of the major success stories of all of medicine. The new therapies that we have, particularly when used in combination, are very likely to make the symptoms that the patients have much better and to prolong survival. Hackensack Medical Center has been a major investigator and a major therapy center for multiple myeloma for many years. We're in Philadelphia and our patients have benefited from the educational materials that come out of Hackensack about their support group and potential investigational therapies there. We have a very nice relationship and their patients will benefit from our center also.